Literature DB >> 974493

Long-term low-dose co-trimoxazole in prophylaxis of childhood urinary tract infection: bacteriological aspects.

R N Grüneberg, J M Smellie, A Leakey, W S Atkin.   

Abstract

The bacteriological consequences of giving long-term low-dose co-trimoxazole to children to prevent reinfection of the urinary tract were studied. Only six "break-through" infections occurred during 2637 child-months of prophylaxis. The children complied well with treatment. During prophylaxis the number of rectal coliform bacilli recovered was greatly and rapidly reduced, but at least 70% of the surviving coliform organisms remained sensitive to the two components of co-trimoxazole. Changes in sensitivity pattern were evident within a month of starting treatment and the proportion of rectal organisms resistant to sulphonamide or trimethoprim did not increase with time. After stopping co-trimoxazole prophylaxis the number of rectal organisms recoverable returned rapidly to normal, as did their sensitivities to trimethoprim and sulphonamide. Further episodes of urinary tract infection developing after prophylaxis was stopped were caused by organisms sensitive to a wide range of antimicrobial agents, including trimethoprim.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 974493      PMCID: PMC1687375          DOI: 10.1136/bmj.2.6029.206

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  5 in total

1.  Bowel flora in urinary tract infection: effect of chemotherapy with special reference to cotrimoxazole.

Authors:  R N Grüneberg; A Leakey; M J Bendall; J M Smellie
Journal:  Kidney Int Suppl       Date:  1975-08       Impact factor: 10.545

2.  Susceptibility of urinary pathogens to various antimicrobial substances: a four-year study.

Authors:  R N Grüneberg
Journal:  J Clin Pathol       Date:  1976-04       Impact factor: 3.411

3.  The effect of a combined preparation of trimethoprim and sulphamethoxazole following short-term and long-term administration on the flora of the human gut.

Authors:  H Knothe
Journal:  Chemotherapy       Date:  1973       Impact factor: 2.544

4.  Faecal flora after prolonged co-trimoxazole treatment.

Authors:  D C Speller; D M Bruten
Journal:  Br Med J       Date:  1972-08-12

5.  Effect of trimethoprim on the occurrence of drug-resistant coliform bacteria in the faecal flora.

Authors:  A Toivanen; A Kasan; H Sundquist; P Toivanen
Journal:  Chemotherapy       Date:  1976       Impact factor: 2.544

  5 in total
  7 in total

Review 1.  Antimicrobial prophylaxis.

Authors:  J Smith; A Finn
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

Review 2.  Urinary infections in children 1985.

Authors:  J M Smellie; I C Normand
Journal:  Postgrad Med J       Date:  1985-10       Impact factor: 2.401

3.  [Prospective alternating comparisons of the operative and nonoperative treatment of vesico-renal reflux].

Authors:  H Olbing
Journal:  Klin Wochenschr       Date:  1985-09-16

4.  Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.

Authors:  R L Guerrant; S J Wood; L Krongaard; R A Reid; R H Hodge
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

5.  Prophylactic co-trimoxazole and trimethoprim in the management of urinary tract infection in children.

Authors:  J M Smellie; R N Grüneberg; H M Bantock; N Prescod
Journal:  Pediatr Nephrol       Date:  1988-01       Impact factor: 3.714

Review 6.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

Review 7.  Urinary tract infection in pediatrics: an overview.

Authors:  Ana Cristina Simões E Silva; Eduardo A Oliveira; Robert H Mak
Journal:  J Pediatr (Rio J)       Date:  2019-11-26       Impact factor: 2.990

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.